Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicholas C Dracopoli

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Current Molecular Medicine|February 22, 2005
Development of oncology drug response markers using transcription profilingNicholas C Dracopoli
Cancer Chemotherapy and Pharmacology|July 12, 2003
Pharmacogenomic applications in clinical drug developmentNicholas C Dracopoli
Trends in Pharmacological Sciences|October 30, 2016
The Evolution of Oncology Companion Diagnostics from Signal Transduction to Immuno-OncologyNicholas C Dracopoli, Mark S Boguski
Current Opinion in Pharmacology|July 16, 2008
KRAS mutations predict response to EGFR inhibitorsMitch Raponi, Hans Winkler, Nicholas C Dracopoli
Cancer Research|October 6, 2005
Oncogenomics 2005 meeting report: dissecting cancer through genome researchEllen G Feigal, Nicholas C Dracopoli, Jeffrey M Trent
Journal for Immunotherapy of Cancer|September 11, 2023
Cell-free DNA approaches for cancer early detection and interceptionJamie E Medina, Nicholas C Dracopoli, Peter B Bach, et al.
Pharmacogenetics and Genomics|September 17, 2008
Genetic and gene expression studies implicate renin and endothelin-1 in edema caused by peroxisome proliferator-activated receptor gamma agonistsWilliam J Geese, William Achanzar, Cindy Rubin, et al.
Stroke|October 22, 2005
Evaluation of the paraoxonases as candidate genes for stroke: Gln192Arg polymorphism in the paraoxonase 1 gene is associated with increased risk of strokeKoustubh Ranade, Todd G Kirchgessner, Olga A Iakoubova, et al.
Chest|April 28, 2023
Cell-Free DNA Fragmentomes in the Diagnostic Evaluation of Patients With Symptoms Suggestive of Lung CancerAlessandro I C Leal, Dimitrios Mathios, Debbie Jakubowski, et al.
Nature Communications|October 21, 2024
Cancer treatment monitoring using cell-free DNA fragmentomesIris van 't Erve, Bahar Alipanahi, Keith Lumbard, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Current Molecular Medicine|February 22, 2005
Development of oncology drug response markers using transcription profilingNicholas C Dracopoli
Cancer Chemotherapy and Pharmacology|July 12, 2003
Pharmacogenomic applications in clinical drug developmentNicholas C Dracopoli
Trends in Pharmacological Sciences|October 30, 2016
The Evolution of Oncology Companion Diagnostics from Signal Transduction to Immuno-OncologyNicholas C Dracopoli, Mark S Boguski
Current Opinion in Pharmacology|July 16, 2008
KRAS mutations predict response to EGFR inhibitorsMitch Raponi, Hans Winkler, Nicholas C Dracopoli
Cancer Research|October 6, 2005
Oncogenomics 2005 meeting report: dissecting cancer through genome researchEllen G Feigal, Nicholas C Dracopoli, Jeffrey M Trent
Journal for Immunotherapy of Cancer|September 11, 2023
Cell-free DNA approaches for cancer early detection and interceptionJamie E Medina, Nicholas C Dracopoli, Peter B Bach, et al.
Pharmacogenetics and Genomics|September 17, 2008
Genetic and gene expression studies implicate renin and endothelin-1 in edema caused by peroxisome proliferator-activated receptor gamma agonistsWilliam J Geese, William Achanzar, Cindy Rubin, et al.
Stroke|October 22, 2005
Evaluation of the paraoxonases as candidate genes for stroke: Gln192Arg polymorphism in the paraoxonase 1 gene is associated with increased risk of strokeKoustubh Ranade, Todd G Kirchgessner, Olga A Iakoubova, et al.
Chest|April 28, 2023
Cell-Free DNA Fragmentomes in the Diagnostic Evaluation of Patients With Symptoms Suggestive of Lung CancerAlessandro I C Leal, Dimitrios Mathios, Debbie Jakubowski, et al.
Nature Communications|October 21, 2024
Cancer treatment monitoring using cell-free DNA fragmentomesIris van 't Erve, Bahar Alipanahi, Keith Lumbard, et al.
Pageof 2